Key result
Frontline Penumbra thrombectomy achieves ~88% successful revascularization in large vessel occlusion stroke.
Why the study?
The COMPLETE registry sought to evaluate the generalizability of the safety and efficacy of frontline mechanical thrombectomy with the Penumbra System for large vessel occlusion acute ischemic stroke in a real-world setting.
What is the real-world safety and efficacy of frontline mechanical thrombectomy with the Penumbra System in patients with large vessel occlusion-acute ischemic stroke?
Cohort (n=650)
Open-label
Yes
What is the real-world safety and efficacy of frontline mechanical thrombectomy with the Penumbra System in patients with large vessel occlusion-acute ischemic stroke?
Answers are grounded in this paper and cite their sources.
Demonstrates that frontline mechanical thrombectomy with the Penumbra System in routine real-world clinical practice achieves high revascularization (87.8%) and 90-day functional independence (55.8%) rates comparable to stringent randomized trials, including encouraging outcomes in low ASPECTS and posterior circulation strokes.
BACKGROUND AND PURPOSE: The purpose of the COMPLETE (International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device) registry was to evaluate the generalizability of the safety and efficacy of the Penumbra System (Penumbra, Inc, Alameda) in a real-world setting. METHODS: COMPLETE was a global, prospective, postmarket, multicenter registry. Patients with large vessel occlusion-acute ischemic stroke who underwent mechanical thrombectomy using the Penumbra System with or without the 3D Revascularization Device as frontline approach were enrolled at 42 centers (29 United States, 13 Europe) from July 2018 to October 2019. Primary efficacy end points were successful postprocedure angiographic revascularization (modified Thrombolysis in Cerebral Infarction ≥2b) and 90-day functional outcome (modified Rankin Scale score 0-2). The primary safety end point was 90-day all-cause mortality. An imaging core lab determined modified Thrombolysis in Cerebral Infarction scores, Alberta Stroke Program Early CT Scores, clot location, and occurrence of intracranial hemorrhage at 24 hours. Independent medical reviewers adjudicated safety end points. RESULTS: Six hundred fifty patients were enrolled (median age 70 years, 54.0% female, 49.2% given intravenous recombinant tissue-type plasminogen activator before thrombectomy). Rate of modified Thrombolysis in Cerebral Infarction 2b to 3 postprocedure was 87.8% (95% CI, 85.3%-90.4%). First pass and postprocedure rates of modified Thrombolysis in Cerebral Infarction 2c to 3 were 41.5% and 66.2%, respectively. At 90 days, 55.8% (95% CI, 51.9%-59.7%) had modified Rankin Scale score 0 to 2, and all-cause mortality was 15.5% (95% CI, 12.8%-18.3%). CONCLUSIONS: Using Penumbra System for frontline mechanical thrombectomy treatment of patients with large vessel occlusion-acute ischemic stroke in a real-world setting was associated with angiographic, clinical, and safety outcomes that were comparable to prior randomized clinical trials with stringent site and operator selection criteria. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03464565.
No takes yet. Share an insight, caveat, or question.
Biondi et al. (2021) conducted a cohort in Large vessel occlusion-acute ischemic stroke (LVO-AIS) (n=650). Penumbra System mechanical thrombectomy (direct aspiration alone or combined with 3D Revascularization Device) was evaluated on Successful postprocedure angiographic revascularization (mTICI 2b-3) and 90-day functional independence (mRS 0-2) (95% CI 85.3%-90.4%). Frontline Penumbra System thrombectomy in LVO-AIS achieved 87.8% postprocedure mTICI 2b-3 revascularization, 55.8% 90-day functional independence (mRS 0-2), and 15.5% 90-day mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: